These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 2169547)
21. Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization. Terayama N; Matsui O; Gabata T; Kobayashi S; Sanada J; Ueda K; Kadoya M; Kawamori Y Cardiovasc Intervent Radiol; 2001; 24(6):383-7. PubMed ID: 11907744 [TBL] [Abstract][Full Text] [Related]
22. Palliative treatment of hepatocellular carcinoma with transcatheter arterial embolization. Savastano S; Feltrin GP; Neri D; da Pian P; Chiesura-Corona M; Roman E; Battaglia G; Gerunda G; Lise M; Miotto D Acta Radiol; 1993 Jan; 34(1):26-9. PubMed ID: 7678975 [TBL] [Abstract][Full Text] [Related]
23. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma]. Shi Z; Guo Y; Liu D Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839 [TBL] [Abstract][Full Text] [Related]
24. [The change of hepatic energy status after transcatheter arterial embolization (TAE) for hepatocellular carcinoma--a study using 31P-MRS]. Taniguchi K; Kaminaga T; Sakon M; Umeshita K; Yamada T; Takeda Y; Higaki N; Aoki T; Ohzato H; Hasuike Y; Gotoh M; Murakami T; Nakamura H; Monden M Gan To Kagaku Ryoho; 1997 Sep; 24(12):1632-4. PubMed ID: 9382494 [TBL] [Abstract][Full Text] [Related]
25. The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study. Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee PC; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Chau GY; Chiang JH; Lui WY; Lee SD; Wu JC Liver Int; 2004 Oct; 24(5):419-24. PubMed ID: 15482337 [TBL] [Abstract][Full Text] [Related]
26. [A long surviving hepatocellular carcinoma case (2 years 1 month) with tumor thrombus in the portal trunk treated by embolization]. Hara H; Okazaki M; Ono Y; Nakamura T; Oda Z Rinsho Hoshasen; 1989 Dec; 34(13):1641-4. PubMed ID: 2560084 [TBL] [Abstract][Full Text] [Related]
27. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599 [TBL] [Abstract][Full Text] [Related]
28. [Non-surgical (medical) treatment of hepatocellular carcinoma (HCC)]. Tanikawa K Gan To Kagaku Ryoho; 1989 Jan; 16(1):34-9. PubMed ID: 2536269 [TBL] [Abstract][Full Text] [Related]
29. [Partial liver resection with small skin incision for multidisciplinary treatment of hepatocellular carcinoma]. Masutani S; Tatsuta M; Morimoto O; Ohta H; Hashimoto K; Ikeda M; Miya A; Ishida H; Kawasaki T; Furukawa H; Satomi T; Terai Y Gan To Kagaku Ryoho; 1999 Oct; 26(12):1890-4. PubMed ID: 10560419 [TBL] [Abstract][Full Text] [Related]
30. [Combined hepatic arterial infusion chemotherapy with transcatheter arterial embolization and hyperthermia in primary liver cancer]. Izumi R; Urade M; Kimura H; Kobayashi M; Yabushita K; Watanabe T; Fujimura T; Ohhori I; Itoh M; Yonemura Y Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2465-9. PubMed ID: 2843110 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma]. Kanno T; Harihara S; Kim K; Kimura S; Tamori A; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T; Nakamura K Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):683-7. PubMed ID: 2451472 [TBL] [Abstract][Full Text] [Related]
33. [Advantages and disadvantages of L-TAE in diagnosis and treatment of hepatocellular carcinoma]. Shimamura Y; Ishii M; Shima Y; Takenaka H; Taniguchi H; Watanabe H; Kitai S; Sugai S; Takahashi A; Kitaya T Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2535-9. PubMed ID: 2843119 [TBL] [Abstract][Full Text] [Related]
34. Changes in hepatic lobe volume in hepatocellular carcinoma after transcatheter arterial and percutaneous transhepatic portal embolization. Hatsuno T; Kaneko T; Inoue S; Sugimoto H; Takeda S; Nakao A Hepatogastroenterology; 2004; 51(60):1820-4. PubMed ID: 15532834 [TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711 [TBL] [Abstract][Full Text] [Related]
36. Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma. Kishimoto W; Nakao A; Takagi H; Hayakawa T Am J Gastroenterol; 1989 Nov; 84(11):1396-9. PubMed ID: 2479261 [TBL] [Abstract][Full Text] [Related]
37. Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinomas. Taourel P; Dauzat M; Lafortune M; Pradel J; Rossi M; Bruel JM Radiology; 1994 Apr; 191(1):189-92. PubMed ID: 8134569 [TBL] [Abstract][Full Text] [Related]
38. Portal hemodynamics in patients with hepatocellular carcinoma. Moriyasu F; Ban N; Nishida O; Nakamura T; Soh Y; Miura K; Sakai M; Miyake T; Uchino H Radiology; 1986 Dec; 161(3):707-11. PubMed ID: 3024207 [TBL] [Abstract][Full Text] [Related]
39. [Growth rate of hepatocellular carcinoma and nutritional state]. Akamatsu K; Tada K; Ito Y; Ohkubo K Gan To Kagaku Ryoho; 1992 May; 19(5):607-11. PubMed ID: 1316099 [TBL] [Abstract][Full Text] [Related]
40. Improved liver function following infusion of fructose-1, 6-bisphosphate in posthepatectomy patients. Nakai T; Tanimura H; Yamoto H; Hirokawa F Nihon Geka Hokan; 1996 Jan; 65(1):3-12. PubMed ID: 8958696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]